Form 4 Tracker
BridgeBio Pharma, Inc.
BBIO

24 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 22, 2026Jun 22 8:06 PMHANNAH A VALANTINE
Proposed Sale
2,808$68.00$190.9K

View →

Jun 15, 2026Jun 17 8:45 PMJennifer E. CookDirector
Sale
90,240$66.62$6.0M6,589(D)

View →

Jun 15, 2026Jun 15 9:34 PMJENNIFER COOK
Proposed Sale
90,240$66.62$6.0M

View →

Jun 5, 2026Jun 8 10:01 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$67.88$2.7M4,318,447(I)

View →

Jun 4, 2026Jun 8 10:01 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$67.46$2.7M4,338,447(I)

View →

May 21, 2026May 26 8:54 PMNeil KumarDirector, Chief Executive Officer
Sale
26,103$69.44$1.8M243,327(D)

View →

May 21, 2026May 21 8:32 PMNEIL KUMAR
Proposed Sale
26,103$68.22$1.8M

View →

May 18, 2026May 19 8:30 PMThomas TrimarchiPresident and CFO
Sale
13,651$65.08$888.4K359,194(D)

View →

May 15, 2026May 19 8:25 PMRandal W. ScottDirector
Sale
10,000$67.15$671.5K11,589(D)

View →

May 18, 2026May 18 8:24 PMTHOMAS TRIMARCHI
Proposed Sale
13,651$65.08$888.4K

View →

May 8, 2026May 11 9:15 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$66.91$2.7M4,358,447(I)

View →

May 7, 2026May 11 9:15 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$67.90$2.7M4,378,447(I)

View →

Apr 30, 2026May 4 8:22 PMMaricel ApuliChief Accounting Officer
Sale
2,000$71.58$143.2K134,115(D)

View →

Apr 10, 2026Apr 13 10:06 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$74.60$3.0M4,398,447(I)

View →

Apr 9, 2026Apr 13 10:06 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$74.62$3.0M4,418,447(I)

View →

Apr 9, 2026Apr 9 8:23 PMKUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018
Proposed Sale
120,000$74.14$8.9M

View →

Mar 13, 2026Mar 16 10:05 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$68.80$2.8M4,438,447(I)

View →

Mar 12, 2026Mar 16 10:05 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$68.73$2.7M4,458,447(I)

View →

Mar 13, 2026Mar 13 8:22 PMKUMAR HALDEA FAMILY IRREVOCABLE TRUST
Proposed Sale
140,000$67.98$9.5M

View →

Mar 10, 2026Mar 12 8:15 PMHannah ValantineDirector
Sale
8,671$72.00$624.3K7,465(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 15, 2026Jun 17 8:45 PMJennifer E. CookDirector
Option Exercise
83,088$16.7534,334(D)

View →

May 16, 2026May 19 8:27 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,21597,794(D)

View →

May 15, 2026May 19 8:25 PMRandal W. ScottDirector
Option Exercise
10,000$16.7521,501(D)

View →

Mar 17, 2026Mar 19 8:28 PMNeil KumarDirector, Chief Executive Officer
Grant/Award
144,883$70.94104,313(D)

View →

Mar 10, 2026Mar 12 8:15 PMHannah ValantineDirector
Option Exercise
8,671$27.3617,343(D)

View →

Mar 4, 2026Mar 6 9:57 PMAndrea EllisDirector
Option Exercise
64,921$8.450(D)

View →

Feb 27, 2026Mar 3 9:17 PMHannah ValantineDirector
Option Exercise
25,484$48.450(D)

View →

Feb 16, 2026Feb 18 11:41 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
64,698138,645(D)

View →

Feb 17, 2026Feb 18 11:34 PMRandal W. ScottDirector
Option Exercise
10,000$16.7531,501(D)

View →